Can High-Sensitivity C-Reactive Protein and Ferritin Predict Functional Outcome in Acute Ischemic Stroke? A Prospective Study

REFERENCES

• Youn CS, Choi SP, Kim SH, et al. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med. 2012;30:124–128.
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke. 2001;32:917–924.
   PubMed Web of Science ®Google Scholar
• Giannopoulos S, Kosmidou M, Hatzitolios Al, et al. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke. Neurol Res. 2008;30:727–730.
   PubMed Web of Science ®Google Scholar
• Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30:981–988.
   PubMed Web of Science ®Google Scholar
• Anuk T, Assayag EB, Rotstein R, et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand. 2002;106:196–199.
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32:133–138.
   PubMed Web of Science ®Google Scholar
• Winbeck K, Poppert H, Etgen T, et al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke. 2002;33:2459–2464.
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: A statement for healthcare professionals from the CRP pooling project members. Stroke. 2005;36:1316–1329.
   PubMed Web of Science ®Google Scholar
• Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The “Bergen stroke study.” BMC Neurol. 2009;9: 18–19.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2–8.
   PubMed Web of Science ®Google Scholar
• Hertog HM, Rossum JA, Worp HB, et al. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. J Neurol. 2009;256:2003–2008.
   PubMed Web of Science ®Google Scholar
• Rajeshwar K, Kaul S, Al-Hazzani A, et al. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Inflammation. 2012;35:978–984.
   PubMed Web of Science ®Google Scholar
• Davalos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology. 2000;54: 1568–1574.
   PubMed Web of Science ®Google Scholar
• Armengou A, Davalos A, Fernandez-Real JM, et al. Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke. 1998;29:258–260.
   PubMed Web of Science ®Google Scholar
• Aho K, Harmsen P, Hatano S, Marguardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull World Health Organ. 1980;58:113–130.
   PubMed Web of Science ®Google Scholar
• Grundy SM. Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol. 2002;17:11i–21i.
   Google Scholar
• American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care. 2000;23:S1–5116.
   Web of Science ®Google Scholar
• Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521–1526.
   PubMed Web of Science ®Google Scholar
• Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 1989;20:864–870.
   PubMed Web of Science ®Google Scholar
• Braddom RL, ed. Physical Medicine and Rehabilitation. 3rd ed. Philadelphia: Saunders; 2007.
   Google Scholar
• Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: Reliability of measures of impairment and disability. Int Disabil Stud. 1990;12:6–9.
   PubMedGoogle Scholar
• Canova CR, Courtin C, Reinhart WH. C-reactive protein (CRP) in cerebrovascular events. Atherosclerosis. 1999;147:49–53.
   PubMed Web of Science ®Google Scholar
• Ladenvall C, Jood K, Blomstrand C, et al. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006;37:2018–2023.
   PubMed Web of Science ®Google Scholar
• Rabadi MH, Coar PL, Lukin M, Lesser M, Blass JR Admission C-reactive protein does not predict functional outcomes in patients with strokes in a subacute rehabilitation unit. Am J Phys Med Rehabil. 2008;87:731–739.
   PubMed Web of Science ®Google Scholar
• Ryu SR, Choi IS, Bian RX, et al. The effect of C-reactive protein on functional outcome in ischemic stroke patients. Int J Neurosci. 2009;119:336–344.
   PubMed Web of Science ®Google Scholar
• Erdemoglu AK, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol. 2002;9: 633–637.
   PubMed Web of Science ®Google Scholar
• Corso G, Bottachi E, Brusa A, et al. Is there a prognostic role of C-reactive protein in ischemic stroke? Acta Neurol Scand. 2010;122:209–216.
   Google Scholar
• Chakraborty B, Vishnoi G, Goswami B, et al. Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian patients [published online ahead of print December 14, 2012]. J Stroke Cerebrovasc Dis.
   Web of Science ®Google Scholar
• Song IU, Kim JS, Kim YI, et al. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis. 2009;28: 545–550.
   PubMed Web of Science ®Google Scholar
• Petzold A, Michel P, Stock M, et al. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome. J Stroke Cerebrovasc Dis. 2008;17;196–203.
   PubMedGoogle Scholar
• Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162:217–219.
   PubMed Web of Science ®Google Scholar